Background text container image for FUJIFILM homepage

Partners for Life

Delivering recombinant proteins, viral vaccines and gene therapies to patients requires commitment and partnership. As a CDMO our focus is to combine technical leadership in cell culture, microbial fermentation and gene therapies with world class GMP manufacturing facilities to advance tomorrow’s medicines.

25+ Years of Experience

What We Do

Formulation Development

Balancing the need for speed with robust science with comprehensive and modern analytical and formulation capabilities and technical expertise
Learn More

Saturn

A Monoclonal Antibody Platform for reliable delivery of mAb based therapeutics
Learn More

Apollo X Mammalian Expression

A Mammalian Expression Platform developed for robust, high levels of monoclonal antibody expression designed with manufacturability for the entire life of your product
Learn More

Paveway Microbial Expression

Incorporating key aspects for the delivery of an E.coli based expression process with industry leading titers and suitable for large-scale manufacture using antibiotic-free fermentation
Learn More

Gene Therapy

Delivering scalable Gene Therapy processes.
Learn More

Thought Leadership

You are about to embark on a clinical journey—be it early, pre-clinical investigation or a later phase of the product lifecycle—it’s good to know Thought Leaders are paving the way.
Learn More
Featured
press-releases
brochures
publications
case-study
whitepaper
Press Releases

FUJIFILM Completes Acquisition of Biogen’s Manufacturing Site in Denmark

FUJIFILM Corporation today announced that it has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark (“Hillerød Manufacturing”) from Biogen. Fujifilm invested approximately US$890 million in cash for the transaction.

Learn More
Press Releases

Fujifilm Introduces A 10 Week Cell Line Development Timeline, Apollo™ X

FUJIFILM announces the introduction of a 10 week Cell Line Development timeline with its Apollo™ X, Advanced Mammalian Expression System.

Webinars

Ask The Expert: Aseptic Filling for Gene Therapies and Next-Generation Biologics

Learn More
Press Releases

FUJIFILM Diosynth Biotechnologies Named A Top Ten Healthiest Employer Nationally

Healthiest 100™ recognizes FUJIFILM Diosynth Biotechnologies as a top ten healthiest employer in nation

Learn More
Press Releases

FUJIFILM Diosynth Biotechnologies is Founding Member of the New Center of Innovation and Manufacturing in Boston, MA

FUJIFILM Diosynth Biotechnologies announces its participation as a Founding Member for the establishment of a New Center for Innovation and Manufacturing in Boston, Masasschusetts.

Learn More
Press Releases

FUJIFILM DIOSYNTH BIOTECHNOLOGIES ANNOUNCES $55 MILLION USD INVESTMENT TO EXPAND GENE THERAPY DEVELOPMENT CAPABILITIES

FUJIFILM Diosynth Biotechnologies will be expanding its gene therapy process and analytical development capabilities with the addition of new dedicated laboratories

Learn More
Brochure

Apollo X Brochure

Learn more how we can optimize the cell line development process without compromising quality to reach titers up to 10 g/L in 10 weeks.

Learn More
Brochure

pAVEway Advanced Microbial Expression Platform

Learn more about our innovative microbial expression system for large-scale production of antibiotic-free therapeutic proteins.

Learn More
Brochure

Gene Therapies Brochure

Learn more about our Viral Products Expertise Experience & Capabilities

Learn More
Publications

Mass Spectrometric Conjugate Characterization: Process Qualification of Recombinant Protein–Hapten Conjugation

Here we present case studies in development of reliable methods based on mass spectrometry (MS) to characterize a protein–hapten drug substance during late-phase process validation. This protein is modified by succinylation to enable conjugation with an aminated hapten.

Learn More
Publications

Rapid Development of High-Quality, Robust Mammalian Cell Culture Manufacturing Processes

Learn the approach that our scientists uses to accelerate the development process from gene to finish by shortening the timeline, incorporating quality by design (QbD) principles, and designing the process to be as robust as possible.

Learn More
Case Study

Expanding Single-Use Biomanufacturing

There are key considerations to take into account when expanding with single-use biologics manufacturing. These technologies readily enable duplicate capacity.

Learn More
Case Study

Single-Use Biologics Manufacturing for Long Term Needs

CDMOs can ensure to meet demand with single-use biologics manufacturing technologies. We have 5 key considerations for securing your supply chain and future-proofing your organization.

Learn More
Case Study

Assessing Biologics Manufacturing Needs

When determining the right type of biomanufacturing capacity for your biologics manufacturing needs, there are key considerations to take into account.

Learn More
Whitepapers

Scale-Down Model Development in ambr systems: An Industrial Perspective

High-Throughput (HT) technologies such as miniature bioreactors (MBRs) are increasingly employed within the biopharmaceutical manufacturing industry. Traditionally, these technologies have been utilized for discrete screening approaches during pre-clinical development (e.g., cell line selection and process optimization).

Learn More
Whitepapers

Xtalks from gene to manufacturing

Application of efficient cell line development strategies to deliver reliable, high quality biomanufacturing processes

Learn More
Whitepapers

pAVEwayTM expression system for the efficient expression of therapeutic proteins

The Escherichia coli pAVEwayTM expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimizing many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).

Learn More

Contact Us

We support our customers through the application of good science, our knowledge of the clinical process and our quality driven approach. For inquiries on How We Can Help, contact FUJIFILM Diosynth by completing this form:

Upcoming Events

Antibody, Engineering & Therapeutics

Marriott Marquis San Diego, CA

Phacilitate Leaders World & World Stem Cell Summit 2020

Hyatt Regency Miami 400 South East Second Avenue Miami, FL 33131

View All Events